YCG LLC’s Pfizer PFE Stock Holding History

YCG LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,059	Closed	-$208K	–	41
2019 Q2	$208K	Hold	5,059	–	–	0.03%	40
2019 Q1	$204K	Hold	5,059	–	–	0.04%	36
2018 Q4	$210K	Hold	5,059	–	–	0.04%	36
2018 Q3	$212K	Buy	+5,059	New	+$195K	0.04%	35
2016 Q3	–	Sell	-5,059	Closed	-$169K	–	50
2016 Q2	$169K	Hold	5,059	–	–	0.05%	36
2016 Q1	$142K	Hold	5,059	–	–	0.04%	37
2015 Q4	$155K	Hold	5,059	–	–	0.04%	42
2015 Q3	$151K	Hold	5,059	–	–	0.05%	40
2015 Q2	$161K	Hold	5,059	–	–	0.05%	40
2015 Q1	$167K	Sell	5,059 -1,581	-24%	-$50.3K	0.05%	43
2014 Q4	$196K	Hold	6,640	–	–	0.06%	45
2014 Q3	$186K	Hold	6,640	–	–	0.07%	41
2014 Q2	$187K	Sell	6,640 -3,162	-32%	-$90.1K	0.07%	41
2014 Q1	$298K	Sell	9,802 -5,007	-34%	-$149K	0.12%	40
2013 Q4	$430K	Sell	14,809 -83,793	-85%	-$2.44M	0.18%	44
2013 Q3	$2.69M	Sell	98,602 -1,792	-2%	-$48.8K	1.21%	25
2013 Q2	$2.67M	Buy	+100,394	New	+$2.77M	1.23%	24

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

YCG LLC's PFE Position: Q3 2019 in Review

YCG LLC sold out of Pfizer (PFE) in Q3 2019, closing a stake of 5,059 shares — an estimated $208K sold.

YCG LLC first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $2.69M in Q3 2013. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

YCG LLC reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
YCG LLC sold 5,059 Pfizer shares in Q3 2019, an estimated $208K.
YCG LLC first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
YCG LLC's Pfizer position peaked at $2.69M in Q3 2013.
2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on YCG LLC's 13F filing for Q3 2019, filed 16 Oct 2019.